Here, OP is used in the formulation because of its anticancer drug properties targeting mammalian neuraminidase 1 (Neu1) involved in multistage tumorigenesis [9] for pancreatic [10], triple negative breast [11] and ovarian [12] cancers. Here, NEU1 is linked to cancer.